Literature DB >> 22973425

Diagnosis and management of central hypersomnias.

Karel Sonka1, Marek Susta.   

Abstract

Central hypersomnias are diseases manifested in excessive daytime sleepiness (EDS) not caused by disturbed nocturnal sleep or misaligned circadian rhythms. Central hypersomnias includes narcolepsy with and without cataplexy, recurrent hypersomnia, idiopathic hypersomnia, with and without long sleep time, behaviorally induced insufficient sleep syndrome, hypersomnia and narcolepsy due to medical conditions, and finally hypersomnia induced by substance intake. The Epworth Sleepiness Scale is a subjective tool mostly used for EDS assessment, while the Multiple Sleep Latency Test serves as an objective diagnostic method for narcolepsy and idiopathic hypersomnias. As for symptomatic therapy of EDS, the central nervous system stimulants modafinil and methylphenidate seem to work well in most cases and in narcolepsy and Parkinson's disease; sodium oxybate also has notable therapeutic value.

Entities:  

Keywords:  Excessive daytime sleepiness; hypersomnia; methylphenidate; modafinil; narcolepsy; sodium oxybate

Year:  2012        PMID: 22973425      PMCID: PMC3437530          DOI: 10.1177/1756285612454692

Source DB:  PubMed          Journal:  Ther Adv Neurol Disord        ISSN: 1756-2856            Impact factor:   6.570


  51 in total

Review 1.  Recurrent hypersomnia: a review of 339 cases.

Authors:  Michel Billiard; Isabelle Jaussent; Yves Dauvilliers; Alain Besset
Journal:  Sleep Med Rev       Date:  2010-10-20       Impact factor: 11.609

2.  Obesity accompanies narcolepsy with cataplexy but not narcolepsy without cataplexy.

Authors:  Karel Sonka; David Kemlink; Jitka Busková; Martin Pretl; Zuzana Srůtková; Eszter Maurovich Horvat; Pavel Vodicka; Veronika Poláková; Sona Nevsímalová
Journal:  Neuro Endocrinol Lett       Date:  2010       Impact factor: 0.765

3.  Modafinil ameliorates excessive daytime sleepiness after traumatic brain injury.

Authors:  P R Kaiser; P O Valko; E Werth; J Thomann; J Meier; R Stocker; C L Bassetti; C R Baumann
Journal:  Neurology       Date:  2010-11-16       Impact factor: 9.910

4.  Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy.

Authors:  Sophie Lavault; Yves Dauvilliers; Xavier Drouot; Smaranda Leu-Semenescu; Jean-Louis Golmard; Michel Lecendreux; Patricia Franco; Isabelle Arnulf
Journal:  Sleep Med       Date:  2011-05-14       Impact factor: 3.492

5.  The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsy.

Authors:  Jed Black; Daniel Pardi; Carl S Hornfeldt; Neil Inhaber
Journal:  J Clin Sleep Med       Date:  2010-12-15       Impact factor: 4.062

6.  Idiopathic hypersomnia: clinical features and response to treatment.

Authors:  Mohsin Ali; R Robert Auger; Nancy L Slocumb; Timothy I Morgenthaler
Journal:  J Clin Sleep Med       Date:  2009-12-15       Impact factor: 4.062

7.  Subjective symptoms in idiopathic hypersomnia: beyond excessive sleepiness.

Authors:  Cyrille Vernet; Smaranda Leu-Semenescu; Marie-Annick Buzare; Isabelle Arnulf
Journal:  J Sleep Res       Date:  2010-12       Impact factor: 3.981

8.  Symptomatic narcolepsy in patients with neuromyelitis optica and multiple sclerosis: new neurochemical and immunological implications.

Authors:  Takashi Kanbayashi; Takayoshi Shimohata; Ichiro Nakashima; Hiroaki Yaguchi; Ichiro Yabe; Masatoyo Nishizawa; Tetsuo Shimizu; Seiji Nishino
Journal:  Arch Neurol       Date:  2009-12

9.  Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study.

Authors:  William G Ondo; Thomas Perkins; Todd Swick; Keith L Hull; J Ernesto Jimenez; Tippy S Garris; Daniel Pardi
Journal:  Arch Neurol       Date:  2008-10

10.  Normal levels of cerebrospinal fluid hypocretin-1 and daytime sleepiness during attacks of relapsing-remitting multiple sclerosis and monosymptomatic optic neuritis.

Authors:  S Knudsen; P J Jennum; K Korsholm; S P Sheikh; S Gammeltoft; J L Frederiksen
Journal:  Mult Scler       Date:  2008-05-27       Impact factor: 6.312

View more
  9 in total

1.  Idiopathic Hypersomnia-A Dynamic Simulation Model.

Authors:  Marek Susta; Karel Šonka; Gustav Bizik; Svojmil Petranek; Sona Nevsimalova
Journal:  Front Neurol       Date:  2022-06-10       Impact factor: 4.086

Review 2.  The autoimmune basis of narcolepsy.

Authors:  Josh Mahlios; Alberto K De la Herrán-Arita; Emmanuel Mignot
Journal:  Curr Opin Neurobiol       Date:  2013-05-29       Impact factor: 6.627

3.  Experience with the use of modafinil in the treatment of narcolepsy in a outpatient facility specialized in diurnal excessive sleepiness in São Paulo.

Authors:  Nilce Sanny Costa da Silva Behrens; Eduardo Lopes; Danielle Pereira; Hassana de Almeida Fonseca; Paola Oliveira Cavalcanti; Taís Figueiredo de Araújo Lima; Marcia Pradella-Hallinan; Juliana Castro; Sergio Tufik; Fernando Morgadinho Santos Coelho
Journal:  Sleep Sci       Date:  2014-08-20

4.  The use of citalopram for the treatment of cataplexy.

Authors:  Hassana de Almeida Fonseca; Danielle Antunes Lopes; Danielle Pereira; Danilo Anunciatto Sguillar; Eduardo Lopes; Nilce Sanny Costa da Silva Behrens; Taís Figueiredo de Araújo Lima; Marcia Pradella-Hallinan; Juliana Castro; Sergio Tufik; Fernando Morgadinho Santos Coelho
Journal:  Sleep Sci       Date:  2014-09-04

5.  Impact of social media usage on daytime sleepiness: A study in a sample of tertiary students in Singapore.

Authors:  A M A Nasirudeen; Lau Lee Chin Adeline; Koh Wat Neo Josephine; Lim Lay Seng; Li Wenjie
Journal:  Digit Health       Date:  2017-04-16

6.  Physical Activity and Executive Functions in Adolescents: The Mediating Role of Sleepiness.

Authors:  Fenghua Sun; Fan Zhang; Karen Ying-Fung Ho; Borui Zhang; Zixin Wang; Andy Choi-Yeung Tse
Journal:  Int J Environ Res Public Health       Date:  2022-10-10       Impact factor: 4.614

7.  Modulatory Effects of Caffeine and Pentoxifylline on Aromatic Antibiotics: A Role for Hetero-Complex Formation.

Authors:  Anna Woziwodzka; Marta Krychowiak-Maśnicka; Grzegorz Gołuński; Anna Felberg; Agnieszka Borowik; Dariusz Wyrzykowski; Jacek Piosik
Journal:  Molecules       Date:  2021-06-14       Impact factor: 4.411

Review 8.  Narcolepsy as an immune-mediated disease.

Authors:  Alberto K De la Herrán-Arita; Fabio García-García
Journal:  Sleep Disord       Date:  2014-01-14

9.  Simplified drug efficacy screening system for sleep-disorder drugs using non-human primates.

Authors:  Keita Sakai; Akiyoshi Ishikawa; Yuri Mizuno; Takehiro Maki; Yasuhiro Oda; Eiki Takahashi
Journal:  Heliyon       Date:  2020-03-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.